血浆神经丝轻链可预测心脏骤停后12小时的神经功能结局
这项观察性多中心队列研究纳入428例心脏骤停后入住ICU的成人患者(院外328例、院内100例),回顾性检测入ICU时、骤停后12小时和48小时的血浆NfL,以2-6个月时CPC 1-2为良好结局、CPC 3-5为不良结局,用AUROC评估预测效能。院外心脏骤停后12小时和48小时NfL预测总体结局的AUROC分别为0.93和0.97,预测效能优异;院内心脏骤停后相应AUROC为0.81和0.86,低于院外(p≤0.03)。入ICU时AUROC在院外和院内心脏骤停分别为0.77和0.67。院外心脏骤停后12小时和48小时,高NfL以95%特异度预测不良结局的敏感度分别为70%和89%。
要点
- 院外心脏骤停后12小时血浆NfL预测总体神经结局AUROC 0.93,48小时0.97,作者认为早至12小时预测良好与不良结局的准确性优异。
- 院内心脏骤停后12小时和48小时NfL的AUROC分别为0.81和0.86,低于院外心脏骤停(p≤0.03),作者认为院内心脏骤停后NfL预测结局较不可靠。
- 院外心脏骤停后12小时高NfL以95%特异度预测不良结局的敏感度为70%,48小时为89%。
- 院外心脏骤停后12小时低NfL以95%敏感度预测良好结局的特异度为71%、阴性预测值86%;48小时特异度74%、阴性预测值88%。
- 入ICU时NfL的AUROC在院外心脏骤停为0.77、院内心脏骤停为0.67,早期预测效能低于12小时和48小时。
适用人群与场景
- 成人心脏骤停后入住ICU的患者,包括院外心脏骤停328例(77%)和院内心脏骤停100例(23%)。
诊断标准与关键阈值
- 结局评估采用2至6个月时的脑功能分类(CPC)量表,CPC 1-2视为良好结局,CPC 3-5视为不良结局。
研究设计与关键结果
- 观察性多中心队列研究,共428例成人心脏骤停后入住ICU患者,其中院外心脏骤停328例(77%)、院内心脏骤停100例(23%);不良结局在院外心脏骤停占68%、院内心脏骤停占55%。
- 回顾性检测入ICU时、骤停后12小时和48小时采集的血浆NfL,预测2至6个月时CPC 3-5的不良结局。
- 院外心脏骤停后12小时和48小时NfL预测总体结局的AUROC分别为0.93和0.97;院内心脏骤停后相应AUROC为0.81和0.86,低于院外心脏骤停(p≤0.03)。
- 入ICU时NfL的AUROC在院外心脏骤停为0.77、院内心脏骤停为0.67。
- 院外心脏骤停后12小时和48小时,高NfL以95%特异度预测不良结局的敏感度分别为70%和89%。
- 院外心脏骤停后12小时和48小时,低NfL以95%敏感度预测良好结局的特异度分别为71%和74%,阴性预测值分别为86%和88%。
证据类型、等级与局限
- 证据类型:观察性多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,NfL预测良好与不良结局的准确性早至院外心脏骤停后12小时即优异,但用于院内心脏骤停后结局预测较不可靠。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Previous studies have reported high prognostic accuracy of circulating neurofilament light (NfL) at 24-72 h after out-of-hospital cardiac arrest (OHCA), but performance at earlier time points and after in-hospital cardiac arrest (IHCA) is less investigated. We aimed to assess plasma NfL during the first 48 h after OHCA and IHCA to predict long-term outcomes.
METHODS: Observational multicentre cohort study in adults admitted to intensive care after cardiac arrest. NfL was retrospectively analysed in plasma collected on admission to intensive care, 12 and 48 h after cardiac arrest. The outcome was assessed at two to six months using the Cerebral Performance Category (CPC) scale, where CPC 1-2 was considered a good outcome and CPC 3-5 a poor outcome. Predictive performance was measured with the area under the receiver operating characteristic curve (AUROC).
RESULTS: Of 428 patients, 328 (77%) suffered OHCA and 100 (23%) IHCA. Poor outcome was found in 68% of OHCA and 55% of IHCA patients. The overall prognostic performance of NfL was excellent at 12 and 48 h after OHCA, with AUROCs of 0.93 and 0.97, respectively. The predictive ability was lower after IHCA than OHCA at 12 and 48 h, with AUROCs of 0.81 and 0.86 (p ≤ 0.03). AUROCs on admission were 0.77 and 0.67 after OHCA and IHCA, respectively. At 12 and 48 h after OHCA, high NfL levels predicted poor outcome at 95% specificity with 70 and 89% sensitivity, while low NfL levels predicted good outcome at 95% sensitivity with 71 and 74% specificity and negative predictive values of 86 and 88%.
CONCLUSIONS: The prognostic accuracy of NfL for predicting good and poor outcomes is excellent as early as 12 h after OHCA. NfL is less reliable for the prediction of outcome after IHCA.
参考来源
- Levin H, Lybeck A, Frigyesi A, et al. Plasma neurofilament light is a predictor of neurological outcome 12 h after cardiac arrest. Crit Care. 2023. PMID: 36829239. doi:10.1186/s13054-023-04355-3
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。